Outlast Bioscience develops targeted, non-hormonal solutions that restore and maintain a resilient vaginal microbiome — one scientific platform, powering products that support women's health across every stage of life.
The vaginal microbiome shapes women's health at every life stage — yet no consumer product is engineered to actively rebalance it. The numbers describe a problem hiding in plain sight.
women experience bacterial vaginosis (BV) in any given year.
CDC / Peebles et al.BV recurrence within 12 months of standard antibiotic treatment.
Bradshaw et al., JIDof women over 48 experience vaginal dryness — most with no microbiome-aware option.
Reckitt Intimate HealthExisting "microbiome-friendly" products are passive — they merely avoid harm. None of them actively restore, rebalance, or recover the vaginal microbiota.
The vagina is home to a living ecosystem — a community of microorganisms that protects, adapts, and responds throughout a woman's life. When it thrives, she thrives.
A healthy vaginal microbiota is dominated by protective Lactobacillus species — above all L. crispatus. They produce lactic acid, maintain a low pH, and form a natural barrier against pathogens.
Hormonal shifts, antibiotics, intimate products, sex, and life stages such as menopause can tip the ecosystem into dysbiosis — an imbalance linked to discomfort, bacterial vaginosis, recurrent infections, fertility issues, and reduced quality of life.
Antibiotics clear symptoms but also clear the protectors — imbalance frequently returns. Hormonal therapies are not right for every woman. Most intimate products are, at best, passive: they avoid harm but do not restore the vaginal microbiota.
Advances in microbiome science make it possible to selectively nourish the protective species while suppressing the disruptive ones — actively guiding the ecosystem back to balance, without hormones or antibiotics.
Solutions that rebuild the protective microbiota — rather than wiping it out — could break the cycle of recurrent bacterial vaginosis, reduce reliance on repeated antibiotics, and give women options that work with their biology.
A resilient vaginal ecosystem means more than symptom relief: everyday comfort and confidence, support for fertility and healthy pregnancies, healthier transitions through menopause, and long-term vaginal health well beyond menopause — all built on a woman's own microbiome.
The question is no longer whether the vaginal microbiome matters — it is how to restore it, precisely and durably.
We develop targeted, non-hormonal solutions that restore and maintain a resilient vaginal ecosystem. Built on one scientific platform, our products support beneficial bacteria to improve women's health across every stage of life.
Support the protective vaginal microbiome in everyday intimate life, helping maintain a resilient ecosystem when it is most vulnerable to disruption.
Help restore microbial balance during hormonal transitions, including menopause, when the loss of protective lactobacilli contributes to vaginal discomfort and declining vaginal health.
Restore a healthy vaginal ecosystem following dysbiosis, offering a non-antibiotic approach for recurrent bacterial vaginosis and other microbiome-related conditions where current treatments often fail to provide lasting benefit.
One microbiome platform. A lifetime of women's health solutions.
From intimate wellness to clinically validated medical devices, every product is powered by the same microbiome-guided platform. Built on one proprietary scientific foundation, our pipeline restores and maintains a resilient vaginal ecosystem across multiple indications and every stage of a woman's life.
Clinical evidence programs run in parallel with market availability — wellness products today, medically claimed solutions tomorrow.
For decades, women's intimate health has focused on relieving symptoms or eliminating microbes. Outlast takes a different approach — restoring the resilient vaginal ecosystem that underpins long-term health.
Conventional lubricants focus on comfort. Our proprietary formulation actively supports a resilient vaginal ecosystem during intimacy.
Most non-hormonal menopause products relieve dryness without addressing the underlying microbial changes. We help restore a healthy vaginal ecosystem during hormonal transition.
Current treatment for recurrent bacterial vaginosis often fails to provide lasting benefit because it does not rebuild the protective microbiome. Our non-antibiotic approach is designed to restore ecosystem resilience.
The vaginal microbiome does not exist in isolation. We are pioneering microbiome-guided partner health to help maintain long-term vaginal health and reduce the cycle of reinoculation.
We envision a future where every woman can maintain lifelong vaginal health by restoring — not disrupting — her microbiome, without hormones or antibiotics.
From first intimacy to menopause and beyond: health that lasts, built on the ecosystem a woman already carries.
Outlast Bioscience was founded by a team of microbiome scientists, clinicians and consumer-health operators who saw the same gap from three different angles: women deserve solutions that work with their biology, not against it.
Our platform is powered by an exclusive licence to PhenoBiome's functional-microbiome technology (3,800+ reference genomes, 150+ metabolic pathways) and shaped by scientific leadership from the Karolinska Institutet. We translate that foundation into precise, non-hormonal products that restore and maintain the vaginal microbiome across every stage of a woman's life.
We are building the category standard — from everyday intimate wellness to clinically validated medical devices — under one microbiome-guided platform.
Microbiome scientists, clinicians and consumer-health operators — united by one mission. Hover a card for the full story.
Associate Professor at Karolinska Institutet; expert in women's health and microbiome science. Former biotech CEO with 25+ years across pharma R&D and commercialization. Author of Vulva — and the artist behind the watercolors on this page.
Founder, The Microbiome Mavericks and SwipeBiome. Former Director, Microbiome Excellence Center @ Beiersdorf; former Director of R&D, S-Biomedic (acquired by Beiersdorf). European Commission expert advisor. PhD INRAe; ex-Max Planck.
Obstetrician and gynaecologist. Founder of Quanna. Clinical lead on product reformulation, regulatory strategy and clinical study design. Brings direct OB-GYN perspective to every product decision.
Co-founder, Back to Balance Test. Wellness Specialist at Libi & Daughters; Medical Specialist at Dajani Pharmacies. Operations, manufacturing, retail execution, and day-to-day delivery.
President of PhenoBiome — the microbiome biotech whose functional-profiling platform powers Outlast's formulations. 8× serial entrepreneur across consumer health and biotech. Leads commercial strategy and partnerships.
The watercolor artworks flowing through this page are original works by our co-founder Ina Schuppe Koistinen — science and art, from the same hand.
Outlast's platform is built to scale beyond what one company can deliver alone. We work with partners who share our conviction that the vaginal microbiome is central to women's health — and who want to bring precise, microbiome-guided products to market together.
If you are a retailer, distributor, clinical partner, ingredient supplier or category leader interested in co-development or licensing, we would love to hear from you.
Start a conversationBring Outlast products to your customers — pharmacy, specialty retail, e-commerce and international markets.
Build category-specific products on our microbiome-guided platform, from formulation to clinical evidence.
Partner on studies, pilots and evidence generation across intimate health, menopause and BV.
Contribute expertise, technology or components that advance the microbiome-restoration standard.
Partnerships, science, press, or just curiosity — we would love to hear from you.
info@outlastbio.com